Evidence map›Paper›PMID 41400934›Full record

ArticleMolecular biology of the cell2026

Systematic evaluation of tools for auxin-inducible protein degradation in budding yeast.

Petra Hubbe, Charu Sharma, Oliver Pajonk, Niklas Peters, Nadja Guschtschin-Schmidt, Natalie Friemel, Sebastian Schuck

Abstract read
In one paragraph

Article in Molecular biology of the cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Petra HubbeHeidelberg University Biochemistry Center, 69120 Heidelberg, Germany.ORCID 0009-0000-3599-1826
Charu SharmaHeidelberg University Biochemistry Center, 69120 Heidelberg, Germany.
Oliver PajonkHeidelberg University Biochemistry Center, 69120 Heidelberg, Germany.
Niklas PetersHeidelberg University Biochemistry Center, 69120 Heidelberg, Germany.
Nadja Guschtschin-SchmidtHeidelberg University Biochemistry Center, 69120 Heidelberg, Germany.
Natalie FriemelHeidelberg University Biochemistry Center, 69120 Heidelberg, Germany.
Sebastian SchuckHeidelberg University Biochemistry Center, 69120 Heidelberg, Germany.ORCID 0000-0002-6388-0661

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The auxin system for inducible protein degradation is a powerful tool to investigate protein function. It consists of a degron fused to a target protein, an auxin-related ligand that binds to the degron, and a receptor that recognizes the auxin-bound degron and mediates proteasomal degradation of the target protein. Variants of all system components are available, and we here test three degrons, three auxins and three degron receptors to identify optimal combinations of these variants in budding yeast. We show that the degrons mIAA7 or AID* together with adamantyl-auxin and the degron receptor OsTIR1(F74G) allow particularly rapid and extensive degradation. Basal degradation in the absence of auxin is generally low and can be minimized further by inducible expression of OsTIR1(F74G). Moreover, we demonstrate that the remarkable efficiency of this system makes it competitive with established chemical inhibitors, such as tunicamycin and MG132, and with temperature-sensitive conditional alleles. These findings will aid the effective application of the auxin system.

Indexed as

Indoleacetic AcidsProteolysisSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSaccharomycetalesProteasome Endopeptidase ComplexReceptors, Cell SurfaceIndoleacetic AcidsProteasome Endopeptidase ComplexReceptors, Cell SurfaceSaccharomyces cerevisiae Proteins

Identifiers

PMID41400934
PMCPMC12879018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.